Literature DB >> 27334677

Antenatal steroid administration in medically uncomplicated pregnancy beyond 37 weeks of gestation for the prevention of neonatal morbidities prior to elective caesarean section: a systematic review and meta-analysis of randomised controlled trials.

Ravisha Srinivasjois1,2, Desiree Silva1,2.   

Abstract

BACKGROUND: Elective caesarean section is associated with an increased risk of respiratory morbidity and admission to special care nursery even at full-term gestation. AIM: To systematically review the efficacy of antenatal steroid administration to prevent neonatal morbidity at full-term. Only randomised and quasirandomised controlled trials were selected.
METHODS: Standardised methodology as described by the Cochrane neonatal review group was used for data collection and analysis.
RESULTS: A total of three randomised controlled trials (N = 2740 patients) were included in the review. Meta-analysis of the published data was carried out. A significant decrease in the risk of respiratory distress syndrome (odds ratio (OR) 0.40 (95%CI: 0.23-0.71, p < 0.001), risk of transient tachypnoea of newborn (OR 0.37 (95%CI: 0.25-0.56, p < 0.00001)), risk of admission to special care nursery (OR 0.53 (95%CI: 0.37-0.76, p < 0.0007)) were observed.
CONCLUSION: Although antenatal steroid administration prior to elective caesarean section demonstrated significant benefit in the prevention of neonatal morbidities; however, one need to be cautious before it can be routinely administered because of the paucity of long-term safety data.

Entities:  

Keywords:  Antenatal steroids; elective caesarean section; perinatal mortality; respiratory distress; transient tachypnoea of newborn

Mesh:

Substances:

Year:  2016        PMID: 27334677     DOI: 10.1080/14767058.2016.1205031

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  1 in total

1.  Antenatal corticosteroid therapy (ACT) and size at birth: A population-based analysis using the Finnish Medical Birth Register.

Authors:  Alina Rodriguez; Yingbo Wang; Anohki Ali Khan; Rufus Cartwright; Mika Gissler; Marjo-Riitta Järvelin
Journal:  PLoS Med       Date:  2019-02-26       Impact factor: 11.069

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.